20. November 2009 11:45
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
[More]
20. November 2009 09:23
Dendreon Corporation today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by which time it will respond to Dendreon's amended BLA. Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC).
[More]
20. November 2009 04:23
U.S. Health and Human Services Secretary Kathleen Sebelius is to be commended for publicly stating the government panel opposing mammograms is "an outside independent panel of doctors and scientists who ... do not set federal policy and ... don't determine what services are covered by the federal government."
[More]
20. November 2009 00:52
At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora")., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).
[More]
d813dc78-c992-4259-a39a-c277c8bdb0c2|0|.0
Posted in: Men's Health News | Drug Trial News
Tags: Allergy, Angina, Asthma, Cancer, Cholesterol, Cystitis, Diabetes, Erectile Dysfunction, Incontinence, Interstitial Cystitis, Metabolic Syndrome, New Drug Application, Overactive Bladder, Pediatrics, Premature Ejaculation, Sexual Dysfunction, Stress, Type 2 Diabetes, Urinary Incontinence
19. November 2009 08:36
At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).
[More]
a70e4e7a-e1ac-4c00-9287-42a28bd3aa55|0|.0
Posted in: Men's Health News | Drug Trial News
Tags: Allergy, Angina, Asthma, Cancer, Cholesterol, Cystitis, Diabetes, Erectile Dysfunction, Incontinence, Interstitial Cystitis, New Drug Application, Overactive Bladder, Pediatrics, Premature Ejaculation, Stress, Type 2 Diabetes
19. November 2009 01:08
Male infertility and tackling falling birth rates across Europe will be among the topics addressed at this year's British Andrology Society's annual conference at Queen's University in Belfast.
[More]
2cfd8b6e-984d-43fc-a683-e184a9e8633c|0|.0
Posted in: Men's Health News
Tags: Andrology, Cancer, Dentistry, DNA, Fertility, Infertility, IVF, Obesity, Pregnancy, Smoking, Sperm
18. November 2009 05:47
EGR4 is a master gene responsible for fertility in cryptorchidism. Is gene therapy going to replace surgery?
[More]
18. November 2009 01:30
International prostate cancer expert Dr. Oliver Sartor of Tulane Cancer Center is the first oncologist in the United States to offer patients an experimental new treatment for late-stage prostate cancer through a multi-center clinical trial that is currently recruiting patients at 100 sites across 20 countries worldwide.
[More]
16. November 2009 10:21
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
[More]
ff0dced7-006e-4a03-a98a-cf8c7f078101|0|.0
Posted in: Men's Health News | Drug Trial News
Tags: Apoptosis, Bone, Cancer, Cell, Cell Proliferation, Chemotherapy, Diabetes, Diabetes Mellitus, Dihydrotestosterone, Oncology, Prostate Cancer, Steroid, Type 2 Diabetes
13. November 2009 01:51
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) announced today that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men.
[More]
c564e810-ed6e-4f81-81a1-0b47d359140f|0|.0
Posted in: Men's Health News | Medical Research News
Tags: Anemia, Cancer, Cardiovascular Disease, Dermatology, Diabetes, Gerontology, Immunization, Kidney Disease, Nutrition, Stroke, Testosterone, Vaccine
11. November 2009 06:07
In a recent New York Times article, the American Cancer Society (ACS) ignited a major controversy over the benefits of cancer screening, specifically with regards to their breast and prostate cancer guidelines. In the article, Dr. Otis Brawley, chief medical officer of the ACS, responded to a study in the current issue of the Journal of the American Medical Association.
[More]
11. November 2009 05:29
New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer.
[More]
11. November 2009 03:18
High levels of workplace exposure to Bisphenol-A may increase the risk of reduced sexual function in men, according to a Kaiser Permanente study appearing in the journal Human Reproduction, published by Oxford Journals.
[More]
10. November 2009 02:54
In the November 2009 issue of the Journal of Urology, Stanford Medical School researcher Dr. Rodney Anderson and researchers at the National Center for Pelvic Pain Research, in a new study, demonstrated a high correlation between the location of painful trigger points inside the pelvic floor muscles of men with chronic prostatitis and the location in the body where they routinely complain of pain.
[More]
10. November 2009 02:02
The December issue of European Urology, the official journal of the European Association of Urology, features an article entitled 'Are Infertile Men Less Healthy than Fertile Men? Results of a Prospective Case-Control Survey' by Dr. Andrea Salonia et al. The conclusion is that male factor infertility is associated with a number of medical comorbidities, as objectively scored with the hospital-based Charlson Comorbidity Index.
[More] 
Subscribe